Onderneming Intervacc AB (publ) Nasdaq Stockholm
Aandelen
SE0009607252
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Veterinary Vaccines
100,0
%
| 5 | 100,0 % | 10 | 100,0 % | +84,77% |
Verkoop per regio
SEK in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 5 | 100,0 % | 10 | 100,0 % | +84,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jonas Sohlman
CEO | Chief Executive Officer | - | 21-08-23 |
Jan Persson
DFI | Director of Finance/CFO | - | 06-02-20 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 11-06-20 |
Patrik Hellberg
CIO | Chief Investment Officer | - | - |
Tim Wood
LAW | General Counsel | - | 01-08-18 |
Corporate Officer/Principal | 45 | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Boel Sundvall
BRD | Director/Board Member | 65 | 01-01-23 |
Chairman | 56 | - | |
Edwin Torr
BRD | Director/Board Member | 63 | - |
Director/Board Member | 63 | 01-01-09 | |
Bengt Guss
FOU | Founder | 66 | 01-01-01 |
Niels Holcke
BRD | Director/Board Member | - | 01-01-20 |
Michela de Carli
BRD | Director/Board Member | - | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 75 736 264 | 59 198 500 ( 78,16 %) | 0 | 78,16 % |
Bedrijfsgegevens
Intervacc AB
Västertorpsvägen 135 Hägersten
129 44, Stockholm
+46 8 12 01 06 00
http://www.intervacc.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |